Profile
Robert Zuk is Vice President of Development for ForteBio, Inc. Most recently, he was Vice President of Bio-Development for Pharmasonics from 1998 to 2003.
He held various positions at First Medical, Inc. from 1994 to 1998, Metra Biosystems from 1991 to 1994, Molecular Devices from 1985 to 1990 and Syntex from 1976 to 1985.
Mr. Zuk received a BS degree from the University of California, Riverside.
Former positions of Robert Zuk
| Companies | Position | End |
|---|---|---|
PharmaSonics, Inc.
 PharmaSonics, Inc. Medical SpecialtiesHealth Technology Pharmasonics develops, manufactures and plans to market power ultrasonic interventional cardiology devices to address the problem of restenosis in coronary arteries. Their lead product aims to reduce the rate of restenosis after intervention by applying a therapeutic level of ultrasound radiation to the target lesion | Corporate Officer/Principal | 31/12/2002 |
First Medical, Inc.
 First Medical, Inc. Medical SpecialtiesHealth Technology Part of Merck KGaA, First Medical, Inc. is a company that manufactures blood sample analysis equipment. The company is based in Mountain View, CA. First Medical was acquired by Sigma-Aldrich Corp., part of Merck KGaA from November 19, 2015 on July 24, 2000. | Corporate Officer/Principal | 31/12/1997 |
Metra Biosystems, Inc.
 Metra Biosystems, Inc. Medical SpecialtiesHealth Technology Metra Biosystems Inc was a leader in developing and commercializing diagnostic products for the detection and management of metabolic bone diseases and disorders. The company's strategy is to offer a portfolio of tests that will provide physicians with comprehensive clinical information regarding the metabolism of bone and other connective tissues | Corporate Officer/Principal | 31/12/1993 |
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Corporate Officer/Principal | 31/12/1989 |
| Syntex Corp. | Corporate Officer/Principal | 31/12/1985 |
Training of Robert Zuk
| University of California, Riverside | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
| Syntex Corp. | Health Technology |
Molecular Devices LLC
Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Health Technology |
Metra Biosystems, Inc.
Metra Biosystems, Inc. Medical SpecialtiesHealth Technology Metra Biosystems Inc was a leader in developing and commercializing diagnostic products for the detection and management of metabolic bone diseases and disorders. The company's strategy is to offer a portfolio of tests that will provide physicians with comprehensive clinical information regarding the metabolism of bone and other connective tissues | Health Technology |
First Medical, Inc.
First Medical, Inc. Medical SpecialtiesHealth Technology Part of Merck KGaA, First Medical, Inc. is a company that manufactures blood sample analysis equipment. The company is based in Mountain View, CA. First Medical was acquired by Sigma-Aldrich Corp., part of Merck KGaA from November 19, 2015 on July 24, 2000. | Health Technology |
PharmaSonics, Inc.
PharmaSonics, Inc. Medical SpecialtiesHealth Technology Pharmasonics develops, manufactures and plans to market power ultrasonic interventional cardiology devices to address the problem of restenosis in coronary arteries. Their lead product aims to reduce the rate of restenosis after intervention by applying a therapeutic level of ultrasound radiation to the target lesion | Health Technology |
ForteBio, Inc.
 ForteBio, Inc. Medical SpecialtiesHealth Technology Pall ForteBio Corp. develops analytical systems that enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. The company was founded in October 2001 and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Zuk
